| Product Code: ETC7548404 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India multiple sclerosis treatment market import shipments demonstrated robust growth with a notable CAGR between 2020-2024. The market experienced accelerated expansion from 2023 to 2024, indicating increasing momentum and a strong upward trend in total shipments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Multiple Sclerosis Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Multiple Sclerosis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Multiple Sclerosis Treatment Market - Industry Life Cycle |
3.4 India Multiple Sclerosis Treatment Market - Porter's Five Forces |
3.5 India Multiple Sclerosis Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 India Multiple Sclerosis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 India Multiple Sclerosis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 India Multiple Sclerosis Treatment Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 India Multiple Sclerosis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple sclerosis in India |
4.2.2 Growing awareness about the disease and available treatment options |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 High cost of multiple sclerosis treatments and therapies |
4.3.2 Limited access to specialized healthcare services in remote areas of India |
4.3.3 Lack of skilled healthcare professionals with expertise in multiple sclerosis treatment |
5 India Multiple Sclerosis Treatment Market Trends |
6 India Multiple Sclerosis Treatment Market, By Types |
6.1 India Multiple Sclerosis Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 India Multiple Sclerosis Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 India Multiple Sclerosis Treatment Market Revenues & Volume, By RelapsingRemitting Multiple Sclerosis (RRMS), 2021- 2031F |
6.1.4 India Multiple Sclerosis Treatment Market Revenues & Volume, By Secondary Progressive Multiple Sclerosis (SPMS), 2021- 2031F |
6.1.5 India Multiple Sclerosis Treatment Market Revenues & Volume, By Primary Progressive Multiple Sclerosis (PPMS), 2021- 2031F |
6.1.6 India Multiple Sclerosis Treatment Market Revenues & Volume, By Severe RelapsingRemitting Multiple Sclerosis (RES), 2021- 2031F |
6.2 India Multiple Sclerosis Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 India Multiple Sclerosis Treatment Market Revenues & Volume, By Preventive Therapies, 2021- 2031F |
6.2.3 India Multiple Sclerosis Treatment Market Revenues & Volume, By Abortive Therapies/Treatment of Acute Exacerbations, 2021- 2031F |
6.2.4 India Multiple Sclerosis Treatment Market Revenues & Volume, By Symptomatic Therapies, 2021- 2031F |
6.3 India Multiple Sclerosis Treatment Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 India Multiple Sclerosis Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.3.3 India Multiple Sclerosis Treatment Market Revenues & Volume, By Generic, 2021- 2031F |
6.4 India Multiple Sclerosis Treatment Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 India Multiple Sclerosis Treatment Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F |
6.4.3 India Multiple Sclerosis Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 India Multiple Sclerosis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 India Multiple Sclerosis Treatment Market Import-Export Trade Statistics |
7.1 India Multiple Sclerosis Treatment Market Export to Major Countries |
7.2 India Multiple Sclerosis Treatment Market Imports from Major Countries |
8 India Multiple Sclerosis Treatment Market Key Performance Indicators |
8.1 Number of clinical trials conducted for multiple sclerosis treatments in India |
8.2 Adoption rate of advanced therapies for multiple sclerosis in major cities |
8.3 Percentage of healthcare facilities offering specialized care for multiple sclerosis patients |
9 India Multiple Sclerosis Treatment Market - Opportunity Assessment |
9.1 India Multiple Sclerosis Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 India Multiple Sclerosis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 India Multiple Sclerosis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 India Multiple Sclerosis Treatment Market Opportunity Assessment, By End user, 2021 & 2031F |
10 India Multiple Sclerosis Treatment Market - Competitive Landscape |
10.1 India Multiple Sclerosis Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Multiple Sclerosis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here